Longeveron jumps 21% on launch of Phase 2a Lomecel-B trial for Alzheimer’s Disease
January 05 2022 - 8:22AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Longeveron (NASDAQ:LGVN)
Historical Stock Chart
From Aug 2024 to Sep 2024
Longeveron (NASDAQ:LGVN)
Historical Stock Chart
From Sep 2023 to Sep 2024